Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant–dependent lung carcinomas
J. Clin. Invest. Danan Li, et al. 117:346
doi:10.1172/JCI30446 [Go to this article.]

Problems with a PDF?